|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- September 2, 2005
CopyrightCOPYRIGHT 2005 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Other News To Note Aeolus Pharmaceuticals Inc., of Laguna Niguel, Calif., closed its prior headquarters in Research Triangle Park, N.C., and transferred operations to Southern California. The company is in the process of acquiring additional space. Aeolus is developing therapeutic agents based on its small-molecule catalytic antioxidants. Allos Therapeutics Inc., of Westminster, Colo., said the recent Journal of Clinical Oncology published results from a Phase II study of Efaproxyn (efaproxiral) in patients with unresectable non-small-cell lung cancer (NSCLC) receiving sequential chemoradiotherapy. Results suggested that the addition of Efaproxyn to S-CRT might improve ...
Related newspaper, magazine, and journal articles:
|
|
Article: Local Focus.(Business)
Daily Herald (Arlington Heights, IL);
November 5, 2002 ;
379 words
... ... pact let Hancock or an affiliate buy all of San Gabriel, Calif.-based Fansteel Schulz's capital shares. Before the ... have signed a pact based on Domantis' technology involving domain antibodies, the smallest functional binding units of antibodies. Telular ...
|
|